<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228139/" ref="ordinalpos=4261&amp;ncbi_uid=4096894&amp;link_uid=PMC3228139" image-link="/pmc/articles/PMC3228139/figure/F4/" class="imagepopup">Figure 4. From: Global Profiling of <span class="highlight" style="background-color:">Signaling</span> Networks: Study of Breast Cancer Stem Cells and Potential Regulation. </a></div><br /><div class="p4l_captionBody">Pathway analysis. This chart shows the differences in the gene signaling pathways between SP and non-SP cells. The threshold of significance was defined by the p-value and FDR (p &lt; .01; FDR &lt; .01). All these proteins show increased enrichment, p-values, and FDRs.Abbreviations: FDR, false discovery rate; GnRH, gonadotropin-releasing hormone; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; SP, side population.</div></div>